Recombinant Lassa Virus Expressing Green Fluorescent Protein as a Tool for High-Throughput Drug Screens and Neutralizing Antibody Assays

Mortality Among Confirmed Lassa Fever Cases During the 2015–2016 Outbreak in Nigeria

(2018) Maryam Ibrahim Buba et al.   AMERICAN JOURNAL OF PUBLIC HEALTH

Merimepodib, an IMPDH inhibitor, suppresses replication of Zika virus and other emerging viral pathogens

(2018) Xiao Tong et al.   ANTIVIRAL RESEARCH

Lassa fever in Nigeria: the great unknown

(2018) Talha Burki   LANCET

Deadly Lassa-fever outbreak tests Nigeria's revamped health agency

(2018) Amy Maxmen   NATURE

Nigeria hit by unprecedented Lassa fever outbreak

(2018) Leslie Roberts   SCIENCE

Interactome analysis of the lymphocytic choriomeningitis virus nucleoprotein in infected cells reveals ATPase Na+/K+ transporting subunit Alpha 1 and prohibitin as host-cell factors involved in the life cycle of mammarenaviruses

(2018) Masaharu Iwasaki et al.   PLoS Pathogens

Critical role for cholesterol in Lassa fever virus entry identified by a novel small molecule inhibitor targeting the viral receptor LAMP1

(2018) May Kwang-Mei Wang et al.   PLoS Pathogens

Genomic Analysis of Lassa Virus during an Increase in Cases in Nigeria in 2018

(2018) Katherine J. Siddle et al.   NEW ENGLAND JOURNAL OF MEDICINE

Local, national, and regional viral haemorrhagic fever pandemic potential in Africa: a multistage analysis

(2017) David M Pigott et al.   LANCET

Human-monoclonal-antibody therapy protects nonhuman primates against advanced Lassa fever

(2017) Chad E Mire et al.   NATURE MEDICINE

An LASV GPC pseudotyped virus based reporter system enables evaluation of vaccines in mice under non-BSL-4 conditions

(2017) Qianqian Li et al.   VACCINE

Lassa and Ebola virus inhibitors identified using minigenome and recombinant virus reporter systems

(2016) Stephen R. Welch et al.   ANTIVIRAL RESEARCH

A cell-based high-throughput protocol to screen entry inhibitors of highly pathogenic viruses with Traditional Chinese Medicines

(2016) Yong Yang et al.   JOURNAL OF MEDICAL VIROLOGY

Most neutralizing human monoclonal antibodies target novel epitopes requiring both Lassa virus glycoprotein subunits

(2016) James E. Robinson et al.   Nature Communications

Safety Precautions and Operating Procedures in an (A)BSL-4 Laboratory: 2. General Practices

(2016) Steven Mazur et al.   Jove-Journal of Visualized Experiments

Past, present, and future of arenavirus taxonomy

(2015) Sheli R. Radoshitzky et al.   ARCHIVES OF VIROLOGY

Efficacy of Favipiravir Alone and in Combination With Ribavirin in a Lethal, Immunocompetent Mouse Model of Lassa Fever

(2015) Lisa Oestereich et al.   JOURNAL OF INFECTIOUS DISEASES

Identification and Mechanism of Action of a Novel Small-Molecule Inhibitor of Arenavirus Multiplication

(2015) Nhi Ngo et al.   JOURNAL OF VIROLOGY

Mapping the zoonotic niche of Lassa fever in Africa

(2015) Adrian Q. N. Mylne et al.   TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE

A Recombinant Vesicular Stomatitis Virus-Based Lassa Fever Vaccine Protects Guinea Pigs and Macaques against Challenge with Geographically and Genetically Distinct Lassa Viruses

(2015) David Safronetz et al.   PLoS Neglected Tropical Diseases

The broad-spectrum antiviral favipiravir protects guinea pigs from lethal Lassa virus infection post-disease onset

(2015) David Safronetz et al.   Scientific Reports

A Host-Oriented Inhibitor of Junin Argentine Hemorrhagic Fever Virus Egress

(2014) J. Lu et al.   JOURNAL OF VIROLOGY

Constraints in the diagnosis and treatment of Lassa Fever and the effect on mortality in hospitalized children and women with obstetric conditions in a rural district hospital in Sierra Leone

(2014) A. Dahmane et al.   TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE

The NIAID Integrated Research Facility at Frederick, Maryland: a unique international resource to facilitate medical countermeasure development for BSL-4 pathogens

(2014) Peter B. Jahrling et al.   Pathogens and Disease

Lead optimization of an acylhydrazone scaffold possessing antiviral activity against Lassa virus

(2013) James R. Burgeson et al.   BIOORGANIC & MEDICINAL CHEMISTRY LETTERS

Containing a Lassa fever epidemic in a resource-limited setting: outbreak description and lessons learned from Abakaliki, Nigeria (January–March 2012)

(2013) Nnennaya A. Ajayi et al.   INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES

Mice Lacking Functional STAT1 Are Highly Susceptible to Lethal Infection with Lassa Virus

(2013) N. E. Yun et al.   JOURNAL OF VIROLOGY

Discovery and optimization of potent broad-spectrum arenavirus inhibitors derived from benzimidazole

(2012) Dongcheng Dai et al.   BIOORGANIC & MEDICINAL CHEMISTRY LETTERS

Depletion of GTP pool is not the predominant mechanism by which ribavirin exerts its antiviral effect on Lassa virus

(2011) Stephan Ölschläger et al.   ANTIVIRAL RESEARCH